Analyst price target range
Tarsus Pharmaceuticals Price Target: $99.50 Average
Direct answer
Tarsus Pharmaceuticals's average price target is $99.50.
The verified analyst range runs from $84.00 to $116.00.
The low target implies +10.6%, the high target implies +52.7%, and the range spans 42.1% of the current price.
Forecast evidence checked September 24, 2026.
Get free Tarsus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $75.96
- Average price target
- $99.50
- High price target
- $116.00
- Low price target
- $84.00
- Low target gap
- +10.6%
- Target upside
- +31%
- High target gap
- +52.7%
- Target range width
- 42.1%
- Consensus rating
- Strong Buy
- Analysts
- 10
- Evidence date
- September 24, 2026
- Valid through
- October 1, 2026
Explore related company data
Read the frequently asked questions.
What is Tarsus Pharmaceuticals's average price target?
Tarsus Pharmaceuticals's verified average price target is $99.50. The target range is $84.00 to $116.00.
How far are Tarsus Pharmaceuticals's low and high targets from the recorded price?
The low target implies +10.6%, while the high target implies +52.7%.
How many analysts are included in Tarsus Pharmaceuticals's consensus?
The verified consensus includes 10 analysts.
How is Tarsus Pharmaceuticals's target upside or downside calculated?
The average target of $99.50 is divided by the recorded price of $75.96, then one is subtracted to produce +31%. This does not guarantee a future return.
When was Tarsus Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-09-24. The dataset is valid through 2026-10-01.